XTL BIOPHARMACEUTICALS LTD's ticker is XTLB and the CUSIP is 98386D307. A total of 6 filers reported holding XTL BIOPHARMACEUTICALS LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Noked Capital LTD | 198,888 | $551,000 | 0.14% |
| Noked Israel Ltd | 198,888 | $551,000 | 0.14% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 51,071 | $141,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 153 | $0 | 0.00% |
| Renaissance Technologies | 23,280 | $64,000 | 0.00% |
| UBS Group AG | 154 | $0 | 0.00% |